Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Steen Lindkær-Jensen"'
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e85156 (2014)
Some cases of breast cancer are composed of clones of hormonal-independent growing cells, which do not respond to therapy. In the present study, the effect of Benzene-Poly-Carboxylic Acid Complex (BP-C1) on growth of human breast-cancer cells was tes
Externí odkaz:
https://doaj.org/article/705e1909124544c397178f3ee37a7c09
Autor:
Sagita Dewi, Stig Larsen, Thora J. Jonasdottir, B. Berlinger, Lars Moe, Veronica Kristiansen, Steen Lindkær-Jensen, T. E. Horsberg
Publikováno v:
Veterinary and Comparative Oncology. 15:118-132
The pharmacokinetic profile, tolerability and efficacy of benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride (BP-C1) were studied in dogs with mammary cancer. A three-level response surface pathway designed trial was perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d14dab400a6f2e781a4692d1dd263dd
https://doi.org/10.1111/vco.12144
https://doi.org/10.1111/vco.12144
Autor:
Marina Matrosova, Kritiya Butthongkomvong, Steen Lindkær-Jensen, Vichien Srimuninnimit, Ekaterina Trishkina, Alexey Manikhas, Elena Poddubuskaya, Stig Larsen
Publikováno v:
Breast Cancer : Targets and Therapy
Stig Larsen,1 Kritiya Butthongkomvong,2 Alexey Manikhas,3 Ekaterina Trishkina,4 Elena Poddubuskaya,5 Marina Matrosova,6 Vichien Srimuninnimit,7 Steen Lindkær-Jensen81Department of Controlled Clinical Trials and Biostatistics, Centre for Epidemiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05327188b26f224dca05145d39d2c897
http://europepmc.org/articles/PMC4251531
http://europepmc.org/articles/PMC4251531
Autor:
Steen Lindkaer Jensen, J. Davis, Stephen Marley, Soma Banerjee, Joanna Nicholls, M. Hamady, Abdul Shlebak, Nagy A. Habib, Jeremy Chataway, Myrtle Y. Gordon, Deborah A Williamson, Paul Bentley
Publikováno v:
Stem Cells Translational Medicine. 3:1322-1330
Treatment with CD34+ hematopoietic stem/progenitor cells has been shown to improve functional recovery in nonhuman models of ischemic stroke via promotion of angiogenesis and neurogenesis. We aimed to determine the safety and feasibility of treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2723634beb7c2ef81a6dc30638240e5a
https://doi.org/10.5966/sctm.2013-0178
https://doi.org/10.5966/sctm.2013-0178
Autor:
Ling Peng, Vikash Reebye, Malkhaz Mizandari, Mohamed Emara, Xiaoxuan Liu, Dimitris Zacharoulis, Cheng Liu, Madhava Pai, Duncan Spalding, Steen Lindkær-Jensen, John J. Rossi, Joanna Nicholls, Pål Sætrom, Nikolaos Kostomitsopoulos, Noriyuki Kasahara, Nagy A. Habib, Kai-Wen Huang, Paul J. Mintz, Abdelali Haoudi, Donald A. Tomalia, Piotr Swiderski, Tinatin Chikovani, Long R. Jiao
Publikováno v:
Hepatology. 59:216-227
Hepatocellular carcinoma (HCC) occurs predominantly in patients with liver cirrhosis. Here we show an innovative RNA-based targeted approach to enhance endogenous albumin production while reducing liver tumor burden. We designed short-activating RNAs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7b723aade304063fe7b470270e9c393
https://doi.org/10.1002/hep.26669
https://doi.org/10.1002/hep.26669
Autor:
Sagita Dewi, Vichien Srimuninnimit, Yen-Shen Lu, Stig Larsen, Tjakra Manuaba, Steen Lindkær-Jensen
Publikováno v:
The Open Breast Cancer Journal. 5:7-15
An anti-cancer agent containing benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride (BP-C1) was developed to establish a low toxic and cost effective treatment of breast cancer. The study was aimed to investigate if BP-C1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29007ba76b3d341cf2ac0c79b7fc887e
https://doi.org/10.2174/1876817220130613001
https://doi.org/10.2174/1876817220130613001
Publikováno v:
Journal of Tissue Science & Engineering. 7
The aim of the present study was to test the efficacy of cis-coordinated complexes of platinum (II) with the polymer of benzene-poly-carboxylic acids derived from lignin (CDBPA) (laboratory code BP-C1), an innovative anticancer compound, on the growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05d93bd5637e2fc7f172ff6db8cf244d
https://doi.org/10.4172/2157-7552.1000168
https://doi.org/10.4172/2157-7552.1000168
Autor:
Salah Helmy, Long R. Jiao, Christos Rountas, Paul Tait, Michael S. Scott, Nataša Levičar, Miroslav Milicevic, Shahid A. Khan, Despina Kyriakou, Dimitris Zacharoulis, Stephen B. Marley, Nagy A. Habib, Madhava Pai, Andrew V. Thillainayagam, Joanna Nicholls, Kevin Jestice, Myrtle Y. Gordon, Devinder S. Bansi, Maria Glibetic, Jane F. Apperley, Steen Lindkaer Jensen
Publikováno v:
The American Journal of Gastroenterology. 103:1952-1958
Recent advances in regenerative medicine, including hematopoietic stem cell (HSC) transplantation, have brought hope for patients with severe alcoholic liver cirrhosis (ALC). The aim of this study was to assess the safety and efficacy of administerin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d60d7885244e0e2716584c807abf3aa
https://doi.org/10.1111/j.1572-0241.2008.01993.x
https://doi.org/10.1111/j.1572-0241.2008.01993.x
Autor:
Joanna Nicholls, J. F. Apperley, Paul Tait, Long R. Jiao, Nataša Levičar, C. Smadja, John C. Davis, Francesco Dazzi, Nagy A. Habib, S. B. Marley, Madhava Pai, Myrtle Y. Gordon, Steen Lindkaer Jensen
Publikováno v:
Cell Proliferation. 41:115-125
Evidence is growing in support of the role of stem cells as an attractive alternative in treatment of liver diseases. Recently, we have demonstrated the feasibility and safety of infusing CD34(+) adult stem cells; this was performed on five patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb6e6bc569d7a8faa64b44e5b8248b56
https://doi.org/10.1111/j.1365-2184.2008.00491.x
https://doi.org/10.1111/j.1365-2184.2008.00491.x
Publikováno v:
Journal of Clinical Case Reports.
A successful example of use of a new regenerative substance BP-C2 in a patient with advanced inoperable pancreatic cancer before, during and after chemotherapy is described. The patient was subjected regularly to medical history review, physical exam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d53dd8e750d0f87495a28210748437dd
https://doi.org/10.4172/2165-7920.1000514
https://doi.org/10.4172/2165-7920.1000514